Trials / Completed
CompletedNCT06348849
The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation
The Desensitising Effect of Nanosilver Fluoride Compared to Low-Level Laser Therapy in Molar-Incisor Hypomineralisation: A Randomised Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 7 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the current study is to assess the desensitising effect of nanosilver fluoride on first permanent molars (FPMs) in patients with MIH in comparison to low-level laser therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low-level laser therapy | Wavelength 980nm (SmartM, Lasotronix, Poland) |
| DRUG | Nanosilver fluoride | Optimized synthesis of Nanosilver Fluoride |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-06-01
- Completion
- 2024-08-01
- First posted
- 2024-04-05
- Last updated
- 2025-01-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06348849. Inclusion in this directory is not an endorsement.